scispace - formally typeset
S

Sho Yamasaki

Researcher at Osaka University

Publications -  195
Citations -  11586

Sho Yamasaki is an academic researcher from Osaka University. The author has contributed to research in topics: C-type lectin & Immune system. The author has an hindex of 45, co-authored 156 publications receiving 9894 citations. Previous affiliations of Sho Yamasaki include Chiba University & National Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis

TL;DR: In this paper, the authors synthesized all stereoisomers of 5-OP-RU to investigate the effects of its stereochemistry on the MR1-dependent Mucosal-associated invariant T (MAIT) cell activation and MR1 upregulation.
Journal ArticleDOI

Water-soluble trehalose glycolipids show superior Mincle binding and signaling but impaired phagocytosis and IL-1β production

TL;DR: In this article , a polyethylene glycol modified trehalose glycolipids (PEG-TGLs) with enhanced water solubility and strong murine Mincle (mMincle) binding and signaling was used as a proxy for adjuvanticity.
Posted ContentDOI

InterClone: Store, Search and Cluster Adaptive Immune Receptor Repertoires

TL;DR: The use of InterClone is illustrated with two recently reported examples: searching for Sars-CoV-2 infection-enhancing antibodies in bulk COVID-19 and healthy donor repertoires and identification of SARS-Cov-2 specific TCRs by clustering paired and bulk sequences from CO VID-19, BNT162b2 vaccinated and healthy unvaccinated donors.
Journal ArticleDOI

Necroptosis DAMPens anti-tumor immunity.

TL;DR: It is demonstrated that necroptosis induces PDA progression through the inhibition of anti-tumor immunity, which indicated that blockade of RIP3-mediated signaling changes the tumor microenvironment to unlock immune suppression status and results in tumor regression.